Prevalence of psychiatric disorders among young injection drug users

Drug and Alcohol Dependence

Volumn 124, Issue 1-2, 2012, Pages 70-78

  Mackesy Amiti, Mary E ^a   Donenberg, Geri R ^a   Ouellet, Lawrence J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Comorbidity; Injection drug use; Mental health; Respondent driven sampling

Indexed keywords

ALCOHOL; CANNABIS; COCAINE; DIAMORPHINE; OPIATE; PSYCHEDELIC AGENT; PSYCHOSTIMULANT AGENT; SEDATIVE AGENT;

ADULT; ALCOHOL ABUSE; ALCOHOLISM; ARTICLE; BORDERLINE STATE; CANNABIS ADDICTION; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG ABUSE; DRUG DEPENDENCE TREATMENT; DRUG INDUCED DISEASE; DRUG USE; DSM-IV; DYSTHYMIA; FEMALE; HEROIN DEPENDENCE; HUMAN; INJECTION DRUG USER; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; MORBIDITY; MULTIPLE DRUG ABUSE; PANIC; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRIC RESEARCH INSTRUMENT FOR SUBSTANCE AND MENTAL DISORDERS INTERVIEW; PSYCHIATRIC TREATMENT; PSYCHOLOGIC TEST; PSYCHOPATHY; RELIABILITY; SEX DIFFERENCE;

ADOLESCENT; ADULT; CHICAGO; COMORBIDITY; DIAGNOSIS, DUAL (PSYCHIATRY); DRUG USERS; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MENTAL HEALTH; PREVALENCE; SUBSTANCE ABUSE, INTRAVENOUS;

CANNABIS;

EID: 84861852385     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2011.12.012     Document Type: Article

References (52)

1. Blanco C., Okuda M., Wright C., Hasin D.S., Grant B.F., Liu S.-M., Olfson M. Mental health of college students and their non-college-attending peers: results from the National Epidemiologic Study on Alcohol and Related Conditions. Arch. Gen. Psychiatry 2008, 65:1429-1437.
2. Brady K.T., Dansky B.S., Sonne S.C., Saladin M.E. Posttraumatic stress disorder and cocaine dependence. Order of onset. Am. J. Addict. 1998, 7:128-135.
3. Bremner J.D., Southwick S.M., Darnell A., Charney D.S. Chronic PTSD in Vietnam combat veterans: course of illness and substance abuse. Am. J. Psychiatry 1996, 153:369-375.
4. Brienza R.S., Stein M.D., Chen M., Gogineni A., Sobota M., Maksad J., Hu P., Clarke J. Depression among needle exchange program and methadone maintenance clients. J. Subst. Abuse Treat. 2000, 18:331-337.
5. Brooner R.K., King V.L., Kidorf M., Schmidt C.W., Bigelow G.E. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch. Gen. Psychiatry 1997, 54:71-80.
6. Broz D., Ouellet L.J. Racial and ethnic changes in heroin injection in the United States: implications for the HIV/AIDS epidemic. Drug Alcohol Depend. 2008, 94:221-233.
7. Callaly T., Trauer T., Munro L., Whelan G. Prevalence of psychiatric disorder in a methadone maintenance population. Aust. N. Z. J. Psychiatry 2001, 35:601-605.
8. Caton C.L., Drake R.E., Hasin D.S., Dominguez B., Shrout P.E., Samet S., Schanzer W.B. Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses. Arch. Gen. Psychiatry 2005, 62:9.
9. Chen K.W., Banducci A.N., Guller L., Macatee R.J., Lavelle A., Daughters S.B., Lejuez C.W. An examination of psychiatric comorbidities as a function of gender and substance type within an inpatient substance use treatment program. Drug Alcohol Depend. 2011, 118:92-99.
10. Compton W.M., Cottler L.B., Ben Abdallah A., Phelps D.L., Spitznagel E.L., Horton J.C. Substance dependence and other psychiatric disorders among drug dependent subjects: race and gender correlates. Am. J. Addict. 2000, 9:113-125.
11. Craig R.J., Bivens A., Olson R. MCMI-III-derived typological analysis of cocaine and heroin addicts. J. Pers. Assess. 1997, 69:583-595.
12. Crawford V., Crome I.B., Clancy C. Co-existing problems of mental health and substance misuse (dual diagnosis): a literature review. Drugs Educ. Prev. Pol. 2003, 10:S1-S74.
13. Darke S., Kaye S., Finlay-Jones R. Antisocial personality disorder, psychopathy and injecting heroin use. Drug Alcohol Depend. 1998, 52:63-69.
14. Darke S., Ross J. Polydrug dependence and psychiatric comorbidity among heroin injectors. Drug Alcohol Depend. 1997, 48:135-141.
15. Darke S., Swift W., Hall W. Prevalence, severity and correlates of psychological morbidity among methadone maintenance clients. Addiction 1994, 89:211-217.
16. Des Jarlais D.C. The first and second decades of AIDS among injecting drug users. Br. J. Addict. 1992, 87:347-353.
17. Dinwiddie S.H. Characteristics of injection drug users derived from a large family study of alcoholism. Compr. Psychiatry 1997, 38:218-229.
18. Fendrich M., Mackesy-Amiti M.E. Decreased drug reporting in a cross-sectional student drug use survey. J. Subst. Abuse 2000, 11:161-172.
19. Fendrich M., Warner V. Symptom and substance use reporting consistency over two years for offspring at high and low risk for depression. J. Abnorm. Child Psychol. 1994, 22:425-439.
20. Grant B.F., Dawson D.A., Stinson F.S., Chou S.P., Dufour M.C., Pickering R.P. The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002. Drug Alcohol Depend. 2004, 74:223-234.
21. Grant B.F., Stinson F.S., Dawson D.A., Chou S.P., Dufour M.C., Compton W., Pickering R.P., Kaplan K. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch. Gen. Psychiatry 2004, 61:807-816.
22. Grant B.F., Hasin D.S., Stinson F.S., Dawson D.A., Chou S.P., Ruan W.J., Pickering R.P. Prevalence, correlates, and disability of personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J. Clin. Psychiatry 2004, 65:948-958.
23. Hasin D., Samet S., Nunes E., Meydan J., Matseoane K., Waxman R. Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV. Am. J. Psychiatry 2006, 163:689-696.
24. Hasin D., Trautman K.D., Miele G.M., Samet S., Smith M., Endicott J. Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers. Am. J. Psychiatry 1996, 153:1195-1201.
25. Havassy B.E., Alvidrez J., Owen K.K. Comparisons of patients with comorbid psychiatric and substance use disorders: implications for treatment and service delivery. Am. J. Psychiatry 2004, 161:139-145.
26. Heckathorn D.D. Respondent-driven sampling: a new approach to the study of hidden populations. Soc. Probl. 1997, 44:174-199.
27. Heckathorn D.D. Respondent-driven sampling. II: deriving valid population estimates from chain-referral samples of hidden populations. Soc. Probl. 2002, 49:11-34.
28. Heckathorn D.D. Extensions of respondent driven sampling: analyzing continuous variables and controlling for differential recruitment. Sociol. Methodol. 2007, 37:151-207.
29. Heckathorn D.D., Semaan S., Broadhead R.S., Hughes J.J. Extensions of respondent-driven sampling: a new approach to the study of injection drug users aged 18-25. AIDS Behav. 2002, 6:55-67.
30. Inciardi J.A., Siegal H.A., Surratt H.L. Introduction: health services research among drug abusers. Am. Behav. Sci. 1998, 41:1044-1049.
31. Kessler R.C. The epidemiology of dual diagnosis. Biol. Psychiatry 2004, 56:730-737.
32. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 2005, 62:593-602.
33. Kessler R.C., Chiu W.T., Demler O., Merikangas K.R., Walters E.E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 2005, 62:617-627.
34. Kidorf M., Disney E.R., King V.L., Neufeld K., Beilenson P.L., Brooner R.K. Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program. Drug Alcohol Depend. 2004, 74:115-122.
35. Lenzenweger M.F., Lane M.C., Loranger A.W., Kessler R.C. DSM-IV personality disorders in the National Comorbidity Survey Replication. Biol. Psychiatry 2007, 62:553-564.
36. Mason B.J., Kocsis J.H., Melia D., Khuri E.T., Sweeney J., Wells A., Borg L., Millman R.B., Kreek M.J. Psychiatric comorbidity in methadone maintained patients. J. Addict. Dis. 1998, 17:75-89.
37. Milby J.B., Sims M.K., Khuder S., Schumacher J.E., Huggins N., McLellan A.T., Woody G., Haas N. Psychiatric comorbidity: prevalence in methadone maintenance treatment. Am. J. Drug Alcohol Abuse 1996, 22:95-107.
38. Mills K.L., Teesson M., Darke S., Ross J., Lynskey M. Young people with heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). J. Subst. Abuse Treat. 2004, 27:67-73.
39. Myrick H., Brady K. Current review of the comorbidity of affective, anxiety, and substance use disorders. Curr. Opin. Psychiatry 2003, 16:261-270.
40. Rabkin J.G., Johnson J., Lin S.H., Lipsitz J.D., Remien R.H., Williams J.B., Gorman J.M. Psychopathology in male and female HIV-positive and negative injecting drug users: longitudinal course over 3 years. AIDS 1997, 11:507-515.
41. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., Goodwin F.K. Comorbidity of mental dsorders with alcohol and other drug abuse - results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990, 264:2511-2518.
42. Robins L.N., Helzer J.E., Weissman M.M., Orvaschel H., Gruenberg E., Burke J.D., Regier D.A. Lifetime prevalence of specific psychiatric disorders in three sites. Arch. Gen. Psychiatry 1984, 41:949-958.
43. Rodriguez-Llera M.C., Domingo-Salvany A., Brugal M.T., Silva T.C., Sanchez-Niubo A., Torrens M. Psychiatric comorbidity in young heroin users. Drug Alcohol Depend. 2006, 84:48-55.
44. Schonlau, M., 2010. rds, 1.0. http://www.schonlau.net/stata.
45. Schonlau M., Liebau E. RDS-A Stata Program for Respondent-Driven Sampling. German Stata Users' Group Meeting 2010, Stata Users Group, Berlin.
46. StataCorp Stata Statistical Software: Release 11 2009, StataCorp LP, College Station, TX.
47. Teesson M., Havard A., Fairbairn S., Ross J., Lynskey M., Darke S. Depression among entrants to treatment for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence, correlates and treatment seeking. Drug Alcohol Depend. 2005, 78:309-315.
48. Thorpe L., Ouellet L., Hansen M., Jimenez A.D., Wiebel W.W. Longitudinal findings on HIV risk behavior and seroincidence among injection drug users in Chicago. Am. J. Epidemiol. 1998, 147:S:61.
49. Thorpe L.E., Bailey S.L., Huo D., Monterroso E.R., Ouellet L.J. Injection-related risk behaviors in young urban and suburban injection drug users in Chicago (1997-1999). J. Acquir. Immune Defic. Syndr. 2001, 27:71-78.
50. Tondo L., Baldessarini R.J., Hennen J., Minnai G.P., Salis P., Scamonatti L., Masia M., Ghiani C., Mannu P. Suicide attempts in major affective disorder patients with comorbid substance use disorders. J. Clin. Psychiatry 1999, 60(Suppl. 2):63-69.
51. Wang P.S., Lane M., Olfson M., Pincus H.A., Wells K.B., Kessler R.C. Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 2005, 62:629-640.
52. Weaver T., Madden P., Charles V., Stimson G., Renton A., Tyrer P., Barnes T., Bench C., Middleton H., Wright N., Paterson S., Shanahan W., Seivewright N., Ford C. Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. Br. J. Psychiatry 2003, 183:304-313.